FDA Authorizes First Next Generation Sequence Test for Diagnosing COVID-19
WASHINGTON, D.C. — The U.S. Food and Drug Administration issued an emergency use authorization (EUA) to Illumina, Inc. for the first COVID-19 diagnostic test utilizing next generation sequence technology.
Read More